The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma

ERDEM, Selçuk; YEGEN, Gülçin; Telci, Dilek; YILDIZ, İBRAHİM; TEFIK, Tzevat; İŞSEVER, Halim; KILIÇASLAN, Işın; ŞANLI, Mehmet

doi:10.1007/s00345-014-1462-7

The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma

Atıf İçin Kopyala

ERDEM S., YEGEN G., Telci D., YILDIZ İ., TEFIK T., İŞSEVER H., ...Daha Fazla

WORLD JOURNAL OF UROLOGY, cilt.33, sa.10, ss.1553-1560, 2015 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 33 Sayı: 10
Basım Tarihi: 2015
Doi Numarası: 10.1007/s00345-014-1462-7
Dergi Adı: WORLD JOURNAL OF UROLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1553-1560
Anahtar Kelimeler: Renal cell carcinoma, Transglutaminase 2, Tumor marker, Metastasis, TISSUE TRANSGLUTAMINASE, ADHESION
Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

The aim of this study was to investigate the role of transglutaminase 2(TG2) in renal cell carcinoma (RCC) by comparing the immunohistochemistry staining of primary and metastatic tumor tissues.